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this medication was administered prophylactically at the end of the operation before extubation. The
hematoma rate was 7% in group 1 and 0% in group 2. This study showed that the prophylactic use of
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Abstract Acute hematoma remains one of the most fre-
quently encountered complications after face-lift surgery.
Several risk factors inherent to the patient and omission of
certain intraoperative regimens are considered to cause
hematoma. Significant risk factors include high blood
pressure and male gender. Possible intraoperative regimens
for the prevention of hematoma include tumescence infil-
tration without adrenaline, clotting of raw surfaces with
fibrin glue, usage of drains, and application of compression
bandages. However, little attention has been paid to post-
operative measures. To examine whether different regi-
mens in the postoperative phase can influence the incidence
of hematoma, all face-lift patients who underwent surgery
by a single surgeon in two different clinics (n = 376) with
two different postoperative regimens were evaluated over
the course of 3 years. In group 1 (n = 308), all postoper-
ative medication was administered on request including
medication for pain control, blood pressure stabilization,
and prevention of nausea and vomiting as well as postop-
erative restlessness and agitation. In group 2 (n = 68), this
medication was administered prophylactically at the end of
the operation before extubation. The hematoma rate was
7% in group 1 and 0% in group 2. This study showed that
the prophylactic use of medications (e.g., analgesics, anti-
hypertonics, antiemetics, and sedatives) during the post-
operative phase is superior to making drugs available to
patients on request and can decrease the occurrence of
acute hematoma in face-lift patients.
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Hematoma remains one of the most frequently encountered
acute complications after face-lift surgery [1–4]. A large
expanding hematoma may endanger the vascularity of skin
flaps (Fig. 1) and, at minimum, delay postoperative
recovery due to edema, bruising, or seroma. The long-term
course may even lead to regional hyperpigmentation and
contour changes due to subcutaneous scarring. In the case
of skin necrosis, hematoma may lead to a complicated
healing process requiring secondary surgical interventions.
The reported incidence of hematoma ranges from 2% [5] to
9% [6], but these numbers reflect only large and expanding
hematomas requiring surgical evacuation.
The occurrence of hematoma is attributed to several
causes. A review of 1,078 face-lifts [2] showed significant
associations between hematoma formation and anterior
platysmaplasty, high systolic blood pressure, male gender,
aspirin or nonsteroidal antiinflammatory drugs intake, and
smoking. Among these indicated risk factors, high systolic
blood pressure and male gender have been confirmed
repeatedly [7, 8]. Even patients with such evident risk
factors are not routinely excluded from face-lift surgery.
Thus, numerous strategies have been attempted in an effort
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to prevent hematoma. These strategies include tumescence
infiltration without adrenaline, clotting of raw surfaces with
fibrin glue, usage of drains, and application of compression
bandages.
Surgeons may use particular strategies out of habit. Each
approach has supporters and opponents. For example,
many authors support the use of fibrin glue [9, 10]. Mar-
chac and Sandor [6] reported a statistically significant
decrease in the rate of major hematoma formation associ-
ated with the use of fibrin glue in a study of 200 patients.
Jones et al. [11] found that the use of intrawound vacuum
drains during the first 24 h after surgery significantly
decreased the rate of seroma formation. The occurrence of
hematoma also was reduced, but less dramatically and not
significantly.
In contrast, Huang et al. [12] found that the routine use
of continuous suction drains for patients undergoing rhyt-
idoplasty probably is unnecessary. Similarly, Jones and
Grover [1] found no significant difference in the rate of
hematoma with the use of drains, fibrin, or dressings.
However, a significant reduction was observed in the
incidence of hematoma after withdrawal of adrenaline from
the tumescence infiltration.
Although various controversial studies have investigated
risk factors for the development of hematoma and various
intraoperative measurements for the prevention of hema-
toma, little attention has been paid to postoperative mea-
surements for hematoma prevention. However, the
majority of acute hematomas develop within the first 24 h
postoperatively, even if none of the addressed risk factors
is present, and all suggested preventative intraoperative
measures have been performed.
To examine whether different medical regimens in the
postoperative phase can influence the incidence of hema-
toma, all face-lift patients who underwent surgery by a
single surgeon in two different clinics were evaluated with
regard to risk factors, preventative ancillary intraoperative
measures, and medication during the first 24 h of the
postoperative phase.
Patients and Methods
All 376 patients who underwent face-lifts from January
2005 until December 2008 were evaluated retrospectively.
The study included all patients who underwent an open,
classical cheek–neck lift with lateral removal of the
superficial muscular aponeurotic system [3] combined
with additional submental liposuction when indicated. It
excluded patients with minilifts and frontal face-lifts as
well as those with an open submental lipectomy or an
anterior platysmaplasty. It also excluded patients who had
taken aspirin or nonsteroidal antiinflammatory drugs
during the past 7 days and all patients with an American
Society of Anesthesiologists (ASA) score of 3 (severe
systemic disease, not incapacitating). Data collection
included patient age, gender, blood pressure, concomitant
medical disease and medication, smoking habits, type of
face-lift, and whether the face-lift was a primary or sec-
ondary procedure.
All the operations were performed by a single surgeon
(G.M.B.). All patients received low-molecular-weight
heparin prophylaxis because they had surgery under gen-
eral anesthesia. The heparin prophylaxis started 12 h
before the operation, then was continued every 24 h until
complete mobilization. Anesthesia was induced using
fentanyl combined with propofol and/or sevoflurane.
Endotracheal intubation was performed with the patient
under rocuronium, and anesthesia was maintained with
propofol or sevoflurane using 100% oxygen. To prevent
urinary retention, Foley catheters were used for women.
During the operation, systolic blood pressure was kept
constant between 90 and 110 mmHg. Before the face-lift
operation, we infiltrated the areas to be dissected with an
adrenaline–saline solution (2 mg adrenaline in 500 ml of
0.9% saline solution, 50 ml on each side of the face).
We routinely used the technique of ‘‘second look clo-
sure’’ [3]. This technique involves suturing the first side
only after dissection of the other side, thus allowing a
return to the first side for a ‘‘second look’’ and meticu-
lous hemostasis before the final closure and after the
adrenaline has worn off completely. On each side of the
face, an 8-mm suction drain was inserted and left in
place for 48 h. All patients were supplied with a head
compression bandage for 24 h.
Fig. 1 A large, acute expanding hematoma on the right side in a
woman with drastic edema and bruising 12 h after the operation (the
patient was not from this study; published with permission of the
surgeon)
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In group 1 (n = 308), all necessary postoperative
medications were administered at the patient’s request. The
medications included those for pain control, blood pressure
stabilization, prevention of nausea and vomiting, and pre-
vention of postoperative restlessness and agitation. In
group 2 (n = 68), this medication was administered pro-
phylactically at the end of the operation and before extu-
bation. The prophylactic treatment consisted of 1 g
perfalgan (to control pain), 150 lg clonidine (to stabilize
blood pressure and prevent agitation), and 4 mg ondanse-
tron (to prevent nausea and vomiting). All patients were
additionally observed and monitored carefully for the first
24 h.
The level of care was comparable in the two clinics.
This included the number of nurses during the day and
night watches, the machined monitoring, the number of
face-lift patients per day (1 or a maximum of 2), and the
number of plastic surgeons on duty. In cases of recurrent
pain, perfalgan was administered repeatedly every 6 h. In
cases of severe pain, morphine was added as an externally
controlled intravenous analgesia. When the systolic blood
pressure increased beyond 130 mmHg, additional cloni-
dine was given intravenously. If the patient was known to
experience hypertension, the usual antihypertensive medi-
cation also was added. In addition to monitoring blood
pressure, we recorded qualitative observations of nausea
and vomiting as well as restlessness and agitation.
The patients from groups 1 and 2 were arbitrarily
assigned to one of the two clinics. Hematomas were sub-
classified into acute clinical and subclinical hematomas.
Whereas the former necessitated surgical evacuation within
the first 24 h, the latter were so small that they were left for
spontaneous resorption. [13] Only acute clinical hemato-
mas were collected for this study.
The results were analyzed using SPSS 13.0 (SPSS,
Chicago, IL, USA). Continuous variables were summa-
rized as mean ± standard deviation and compared between
groups using the Mann–Whitney test. Nominal variables
were presented as n (%), and differences were compared
using Fisher‘s exact test. All p values of 0.05 or less were
considered significant (two-tailed test).
Results
The 376 patients in this study included 356 women (95%)
and 20 men (5%) ranging in age from 27 to 89 years
(mean, 58 ± 9 years). In total, 49 patients (13%) had high
blood pressure, 73 patients (19%) were smokers, and 56
patients (15%) had undergone a secondary face-lift.
The two groups separately (308 patients in group 1 and
68 patients in group 2) showed no significant differences in
terms of age, gender distribution, or significant risk factors.
However, group 1 had more smokers. Furthermore, more
patients in group 1 experienced nausea and vomiting as
well as postoperative restlessness and agitation. The data
for both groups are listed in Table 1.
In group 1, 22 patients (7%) experienced acute clinical
hematoma that necessitated surgical evacuation. In group
2, the clinical hematoma incidence was zero, making the
difference in the hematoma rates between the two groups
statistically significant (p = 0.029).
The mean age of the 22 hematoma patients in group 1
was exactly the same as that of the entire group. Further
comparison with the entire group of patients showed that
the hematoma group had more male patients (14%;
p = 0.07) and more patients with a history of high blood
pressure (23%; p = 0.12). In the hematoma group, 18% of
the patients were smokers and 18% had received a sec-
ondary face-lift. One patient displayed two significant risk
factors (male gender and high blood pressure). None of the
11 patients (50%) who experienced acute hematoma had
significant risk factors.
Discussion
This study showed that the incidence of acute clinical
hematoma for the 308 patients undergoing an open face-lift
(group 1) was 7%. For the 68 patients in group 2, the
incidence of hematoma was zero. Regarding significant
risk factors for the development of hematoma in both
groups, the number of patients with high blood pressure
Table 1 Characteristics of the
376 patients receiving face-lifts
in two different clinics
* VP, valid percent (n = 213);
NS, nonsignificant
Group 1 (n = 308, 82%) Group 2 (n = 68, 18%) p
Age 59 ± 9 (38–89) 57 ± 10 (27–78) NS
Sex (F/M) 292/16 (95%/5%) 64/4 (94%/6%) NS
Secondary lift 48 (16%) 8 (12%) NS
Blood pressure (high) 40 (13%) 9 (13%) NS
Nicotine 67 (22%) 6 (9%) 0.02
Nausea & vomiting 11 (5%) VP* 1 (1.5%) NS
Agitation & restlessness 56 (17%) VP* 7 (10%) NS
Hematoma 22 (7%) 0 0.03
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and male gender was comparable high in relation to other
studies [2].
The intraoperative surgical and anesthetic regimen was
comparable across the two groups, and all the patients in
both groups underwent surgery by the same surgeon, which
guaranteed an identical operating style. Additionally, the
patients who had taken aspirin or nonsteroidal antiinflam-
matory drugs during the preceding 7 days were excluded
from the operation. Nevertheless, all the patients received
low-molecular-weight heparin for thrombosis prophylaxis.
In a recent survey by Broughton et al. [14], only 49% of
surgeons performing face-lifts used such a prophylaxis on a
continual basis. Yet, the general guidelines in Europe and
America [15, 16], which are increasingly accepted, state
that operations with patients under general anesthesia
lasting longer than 1 h already have a ‘‘moderate’’ risk for
the development of thromboembolic complications
(thromobembolic risk categories: low, moderate, high,
highest [17]). For patients older than 40 years and those
with additional predisposing and exposing risk factors
(e.g., history of deep venous thrombosis, use of oral con-
traceptives, recent surgery requiring general anesthesia,
obesity), the risk of thromboembolic complications
increases to ‘‘high’’ or ‘‘highest.’’ Thus, patients with a
face-lift under general anesthesia have at least a ‘‘moderate
risk,’’ which means the guidelines dictate the application of
low-molecular-weight heparin for prophylaxis.
Concomitantly to the administration of prophylactic
heparin the question arises whether the rate of bleeding-
related complications increases, and if so, whether the risk-
to benefit ratio justified in face-lift operations. The reports
on this item differ [15]. In one report [18] on ‘‘low-
molecular-weight heparin and postoperative bleeding in
rhytidectomy,’’ the authors observed a bleeding rate of
16% in a low-molecular-weight heparin group of 37
patients. This high hematoma rate likely is related to the
timing of the prophylaxis in this group, which was begun
2 h before surgery. Such a stringent timely regimen has
been known to increase major bleeding [19] and is pre-
served for the highest-risk groups in surgery, such as
elective hip surgery. In contrast, we started the prophylaxis
12 h before surgery (a milder regimen), which results in a
hematoma rate of zero for group 2.
Other studies [20] also found no significant increase in
the hematoma rate after the prophylactic administration of
low-molecular-weight heparin. However, the timing of this
administration also was different in that it was begun
postoperatively.
Concerning the general postoperative phase, medication
was administered at the patient’s request in group 1 and
prophylactically in group 2. Thus, the postoperative med-
ical regimen was the only significantly differing variable in
the two groups.
The postoperative regimen (the phase of postanesthesia
recovery) comprises the control of pain, blood pressure,
nausea and vomiting, and restlessness and agitation. The
intensity of pain after face-lifts usually is moderate. Marin-
Bertolin et al. [21] stated that after superficial operations on
the head and neck, the majority of patients had moderate
pain, with baseline pain scores lower than 4 on a visual
analog scale ranging from 0 to 10, and only 5% to 15% of
patients experienced severe pain.
Despite the expected moderate level of pain, effective
postoperative pain treatment is of major importance. How-
ever, this issue is largely neglected, as observed by Popping
et al. [22] in a recent survey of 19,000 postoperative patients.
Thus, even moderate pain may initiate a dangerous vicious
circle insofar as pain enhances blood pressure, perhaps ini-
tiating nausea and vomiting [23] and leading to restlessness
and agitation. All these factors may ultimately contribute to
the development of acute hematoma.
The medication recommended most frequently for the
control of moderate pain is paracetamol or metamizol.
Either of these two analgesics should be preferred over
aspirin and nonsteroidal antiinflammatory analgesics
because the adverse effects on the clotting function of
thrombocytes is negligibly small [24]. Saray et al. [26]
compared metamizol and diclofenac (a nonsteroidal anti-
inflammatory analgesic) and noted a reduction in platelet
number and prolongation of bleeding time for the majority
of the patients receiving diclofenac. They concluded that
metamizol also is superior to diclofenac for reducing
postoperative pain after plastic surgery. The same applies
to paracetamol [25], which is a safe and effective drug for
the treatment of postoperative pain. Regardless which of
these analgesics is chosen, the most effective manner of
treatment is to administer them prophylactically rather than
on demand. Saray et al. [26] even stated that modern
medical practice dictates the generous use of analgesic
agents as an adjunct or substitute to minimize deleterious
postoperative effects and to facilitate an earlier return to
work and daily activities. Our patients in group 2 reported
that they woke up after the operation with virtually no pain.
Regarding blood pressure in the early postoperative
period, every prophylactic measurement should be under-
taken to prevent its elevation. This claim is unchallenged in
the literature. In representative studies, postoperative blood
pressure was found to be significantly associated with
hematoma after face-lifts [2, 27, 28]. Berner et al.
[28]described a ‘‘reactive hypertension’’ 3–5 h after rhyti-
dectomy that was particularly evident in older patients,
which represent the majority of face-lift clientele (average
age of our patients, 58 years). This is an additional argu-
ment that adequate antihypertensive medication (and
analgesia and sedation) must be applied to reduce the
magnitude of ‘‘reactive hypertension.’’
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A striking example showing that postoperative hema-
toma can be hindered by adequate prophylactic antihy-
pertensive medication is provided by a study on
neurosurgical patients by Vassilouthis et al. [29]. In their
study, 526 consecutive patients underwent craniotomy
under a strict anesthesiologic protocol based on deep
analgesia that virtually eliminated any acute elevations of
arterial pressure during craniotomy and immediately
afterward. It was concluded that postoperative hematoma
probably is an avoidable complication of intracranial sur-
gery. This should also apply to face-lift surgery. Prophy-
laxis with clonidine in the group 2 patients seemed to help
achieve this goal.
The prevention of nausea and vomiting is another major
goal of postoperative care. The factors affecting nausea and
vomiting are patient characteristics, surgical procedure,
anesthetic technique, and postoperative care. Kovac [23]
stated that the overall incidence of postoperative nausea
and emesis is estimated to be 25% to 30%. Female patients
have a 1.5- to 3-fold greater incidence of nausea and
vomiting than males. However, the exact reason for this
difference is unknown [30]. These rates were confirmed in
a study (unpublished) we conducted with 151 patients
(63% women and 37% men). In this study nausea was
experienced by 34% of the men and 16% of the women,
and vomiting, respectively, by 26% and 6%.
Because most of our patients undergoing face-lifts are
women, we consider the prophylactic administration of
antiemetic medications such as ondansetron justified, espe-
cially considering that the costs are paid by the patients
themselves. Patients experience postoperative nausea and
vomiting as two of the most distressing complications.
Similarly, Watcha and White [31] stated that vomiting
should not be considered an unavoidable part of the peri-
operative experience. The availability of an emesis basin for
every patient during postanesthesia recovery is a reflection
of the limited success obtained with the available therapeutic
techniques. Kovac [23] reported that antiserotonin (i.e.,
ondansetron) is highly effective at preventing postoperative
nausea and vomiting for 24 h postoperatively compared
with traditional antiemetics (droperidol and metoclopra-
mide). We observed the same trend in our group 2 patients.
Emergence agitation is a postoperative behavior that
may be experienced by patients undergoing general anes-
thesia [32]. The treatment of choice involves sedatives such
as clonidine and benzodiazepines. The evidence is con-
vincing [33–36] that clonidine leads to evident sedation,
anxiolysis, central anesthesia, and reduced pain sensitivity
at peripheral nerve endings. Thus, it has antihypertensive
properties as well as sedative and analgesic effects. Clo-
nidine has therefore become our drug of choice during the
postoperative phase. Yet, due to a potential for additive
effects such as bradycardia and atrioventricular block,
caution is warranted for patients receiving clonidine con-
comitantly with agents known to affect sinus node function
or atrioventricular nodal conduction (e.g., calcium-channel
blockers and beta-blockers). Yet, the administration of
such medication presents no absolute contraindication
because clonidine can be titrated according the pulse rate
of the patient.
The identity of the clonidine effects most responsible for
preventing hematoma remains obscure. This is one short-
coming of the current retrospective study. The same applies
to some of the quantitatively collected data in this study.
During the postoperative phase, blood pressure was
recorded quantitatively, whereas the other factors were
recorded qualitatively. Thus, the contribution of factors
such as nausea and vomiting or agitation and restlessness to
the occurrence of hematoma remains obscure.
Despite these shortcomings, this survey showed that the
prophylactic administration of postoperative medications
such as analgesics, antihypertonics, antiemetics, and sed-
atives is superior to administration of these drugs at the
request of the patient. Prophylactic administration can
decrease the occurrence of acute hematoma in face-lift
patients, even in patients who routinely receive low-
molecular-weight heparin for thrombosis prophylaxis. The
associated higher costs for prophylactic postoperative
medication will be balanced by the benefits to the patients,
which include a pain-free and convenient postoperative
recovery, with fewer days spent recuperating and reduced
suffering due to chronic pain [24].
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